Large Buying Action and Inflow of Money Witnessed in iShares Nasdaq Biotechnology Index Fund – Highland Mirror

iShares Nasdaq Biotechnology Index Fund (IBB) dropped by -0.35 or -0.98 points during the last session to $282.56 per share. One of the highlights of the day was the net money flow figure, which stood at $2 million even as the stock accepted $4.91 million in upticks but rejected $2.91 million in downticks. The up/down ratio for the last observation was a 1.69. The 1-week percentage change for the stock price is registered at -0.17%.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.

Stock price is down 6.42% since it reached the one year high price and is down $ -19.39 since then. The company shares are up 17.52% from one year low and is up $42.11 since then. The Stock has a 52 week low of $240.3 and one year high of $301.8.

iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) stock ended Tuesday session in the red zone in a volatile trading. The stock closed down 1.13 points or 0.4% at $282.41 with 1,137,322 shares getting traded. Post opening the session at $284.2, the shares hit an intraday low of $280.87 and an intraday high of $284.48 and the price was in this range throughout the day. The company has a market cap of $8,275 million and the number of outstanding shares has been calculated to be 29,300,000 shares. The 52-week high of iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) is $301.8 and the 52-week low is $240.3.

The ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.

Link:
Large Buying Action and Inflow of Money Witnessed in iShares Nasdaq Biotechnology Index Fund - Highland Mirror